Palok Aich

A robustness-first cross-disease framework supports a candidate shared microbial redox axis and disease-specific metabolic divergence in colorectal cancer, Crohn’s disease, and liver cirrhosis

ABSTRACT Gut microbiome dysbiosis is associated with colorectal cancer (CRC), Crohn’s disease (CD), and liver cirrhosis (LC), yet whether these diseases share conserved microbial vulnerabilities remains unresolved. Analytical pipeline choices alone can shift apparent performance...